MammaTyper® is a new tool for subtyping breast cancer.
READ MORE +A rapid, simple, Point Of Care screening test for urinary congophilia.
READ MORE +ABOUT US
Cerca Biotech is the European subsidiary of Shuwen Biotech, a highly reputable and innovative molecular and point of care diagnostics organisation. Shuwen and Cerca are passionate about healthcare and are working to create world-leading innovations in the fields of Oncology and Women’s Health.
Quantitative RT-qPCR assay (CE marked IVD)
Clinical value validated in numerous performance evaluation studies
Clinical value validated in numerous performance evaluation studies
Early diagnosis of Pre-Eclampsia can save lives. Yet, definitive detection of this potentially fatal condition can be delayed or difficult to access under current testing regimes. To help combat this issue, Cerca Biotech is launching a new, rapid point-of-care test designed for use in maternity departments and primary care settings.
We are really pleased to announce that MammaTyper® has been registered by the Ministero della Salute in Italy. This marks a key step towards bringing this innovative, RT-qPCR test to the Italian market and helping women who have been diagnosed with breast cancer. This announcement follows our earlier news that Padua-based firm AB Analytica will be the exclusive distributor for MammaTyper® in Italy.
International Women’s Day is a time to celebrate the social, economic, cultural and political achievements of women everywhere. This year, the focus is on how to #breakthebias that women see in many aspects of their lives.